USANA Health Sciences, Inc. reported a decline in financial performance for the second quarter of 2026, with net sales totaling $223.3 million, a decrease of 5.3% compared to $235.8 million in the same period last year. The company's net loss attributable to USANA was $21.4 million, a significant drop from net earnings of $9.7 million in the prior-year quarter. This downturn was primarily driven by reduced sales in both the Core Nutritional and Hiya segments, which saw declines of $7.9 million and $5.7 million, respectively. The Rise segment, however, experienced a modest increase in sales of $1.0 million.

In terms of operational metrics, USANA's active customer base in the Core Nutritional segment decreased to approximately 384,000, down from 418,000 a year earlier, reflecting an 8.1% decline. The company noted that the decrease in active customers was a key factor contributing to the overall decline in sales. The Core Nutritional segment accounted for about 84% of consolidated net sales during the first half of 2026, with significant contributions from the Asia Pacific region, particularly Greater China, which generated $237.9 million in sales.

Strategically, USANA has been focusing on expanding its product offerings and market reach. The company operates through three reportable segments: Core Nutritional, Hiya, and Rise. The Hiya segment, which specializes in children's health products, has expanded its distribution into Canada and the United Kingdom. Additionally, USANA has integrated its operations with Rise Wellness, Inc., enhancing its product range and distribution channels. However, the company recorded a non-cash goodwill impairment charge of $29.1 million for the Hiya segment due to lower-than-expected performance and changes in near-term forecasts.

The company's financial position remains stable, with cash and cash equivalents increasing to $168.6 million as of July 4, 2026, up from $158.4 million at the beginning of the year. USANA's management expressed confidence in the long-term growth potential of its business, particularly through the Hiya segment, despite the current challenges. Looking ahead, the company aims to leverage its omni-channel platform to enhance customer engagement and drive sales growth, while also navigating the complexities of market conditions and regulatory environments.

About USANA HEALTH SCIENCES INC

USANA Health Sciences, Inc. is a global direct selling and direct-to-consumer company specializing in science-based nutritional, personal care, and skincare products. It operates in 25 markets, primarily through a network of independent Associates and a subscription-based model for its Hiya brand. The company emphasizes product innovation, quality manufacturing, and a rewarding sales structure to promote long-term health and wellness worldwide.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov